EPSYX
Price
$29.31
Change
+$0.20 (+0.69%)
Updated
Jun 12 closing price
Net Assets
979.49M
PRAFX
Price
$19.99
Change
+$0.29 (+1.47%)
Updated
Jun 12 closing price
Net Assets
10.51B
Interact to see
Advertisement

EPSYX vs PRAFX

Header iconEPSYX vs PRAFX Comparison
Open Charts EPSYX vs PRAFXBanner chart's image
EPSYX vs PRAFX Comparison Chart in %
View a ticker or compare two or three
VS
EPSYX vs. PRAFX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPSYX is a Buy and PRAFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRAFX has more cash in the bank: 10.5B vs. EPSYX (979M). PRAFX pays higher dividends than EPSYX: PRAFX (2.58) vs EPSYX (1.68). EPSYX was incepted earlier than PRAFX: EPSYX (20 years) vs PRAFX (16 years). PRAFX (0.93) is less costly to investors than EPSYX (0.88). PRAFX is a more actively managed with annual turnover of: 48.30 vs. EPSYX (30.00). PRAFX has a lower initial minimum investment than EPSYX: PRAFX (2500) vs EPSYX (1000000). PRAFX annual gain was more profitable for investors over the last year : 31.15 vs. EPSYX (24.29). EPSYX return over 5 years is better than : 61.27 vs. PRAFX (42.90).
EPSYXPRAFXEPSYX / PRAFX
Total Expense Ratio0.840.9390%
Annual Report Gross Expense Ratio0.880.9395%
Fund Existence20 years16 years-
Gain YTD19.29911.425169%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets979M10.5B9%
Annual Yield % from dividends1.682.5865%
Returns for 1 year24.2931.1578%
Returns for 3 years57.2653.03108%
Returns for 5 years61.2742.90143%
Returns for 10 years97.77127.5777%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCLAX63.80N/A
N/A
Fidelity Advisor Industrials A
MFRKX58.35N/A
N/A
MFS Research R6
BTSMX25.46N/A
N/A
Boston Trust SMID Cap
AIEMX15.98N/A
N/A
Alger Emerging Markets I
MSPRX21.99N/A
N/A
Morgan Stanley Inst Advantage C